Search

Search Constraints

You searched for: Author/Creator Fortuny, Joan

Search Results

1. Cancer Incidence after Initiation of Antimuscarinic Medications for Overactive Bladder in the United Kingdom: Evidence for Protopathic Bias. Issue 6 (29th May 2017)

2. Overview of the European post‐authorisation study register post‐authorization studies performed in Europe from September 2010 to December 2018. Issue 6 (11th February 2022)

3. Proportions of Cancer Cases in Primary Care, Hospital, and Cancer Registry Data Among Patients Treated for Overactive Bladder. Issue 2 (March 2019)

6. Statin use and risk of multiple myeloma: An analysis from the cancer research network. Issue 3 (15th May 2017)

7. Tiotropium Respimat®vs. HandiHaler®: real‐life usage and TIOSPIR trial generalizability. (23rd December 2015)

8. Use of intravenous iron and risk of anaphylaxis: A multinational observational post‐authorisation safety study in Europe. Issue 10 (12th July 2021)

9. Validation of Cancer Cases Using Primary Care, Cancer Registry, and Hospitalization Data in the United Kingdom. Issue 2 (March 2018)